All Stories

  1. Altered Gene Expression Profiles in Peripheral Blood Mononuclear Cells in Obese Subjects

    Article • Obesity Facts, June 2020, Karger Publishers

    Professor Howard Lee

  2. Failure mode and effects analysis drastically reduced potential risks in clinical trial conduct

    Article • Drug Design Development and Therapy, October 2017, Dove Medical Press

    Professor Howard Lee

  3. New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients

    Article • Drug Design Development and Therapy, September 2017, Dove Medical Press

    Professor Howard Lee

  4. An Accelerator Mass Spectrometry-Enabled Microtracer Study to Evaluate the First-Pass Effect on the Absorption of YH4808

    Article • Clinical Pharmacology & Therapeutics, May 2017, Wiley

    Professor Howard Lee

  5. A novel K+ competitive acid blocker, YH4808, sustains inhibition of gastric acid secretion with a faster onset than esomeprazole: randomised clinical study in healthy volunteers

    Article • Alimentary Pharmacology & Therapeutics, May 2017, Wiley

    Professor Howard Lee

  6. Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013

    Article • Drug Design Development and Therapy, December 2016, Dove Medical Press

    Professor Howard Lee

  7. Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects

    Article • Drug Design Development and Therapy, August 2015, Dove Medical Press

    Professor Howard Lee

  8. A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles

    Article • Drug Design Development and Therapy, May 2015, Dove Medical Press

    Professor Howard Lee, Hyungmi An

  9. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects

    Article • Drug Design Development and Therapy, February 2015, Taylor & Francis

    Professor Howard Lee, Jeong-Ae Kim, Jaeseong Oh

  10. Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers

    Article • Drug Design Development and Therapy, October 2014, Taylor & Francis

    Professor Howard Lee

  11. Predictive performance of gentamicin dosing nomograms

    Article • Drug Design Development and Therapy, August 2014, Dove Medical Press

    Professor Howard Lee, Hyungmi An

  12. Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state

    Article • Drug Design Development and Therapy, June 2014, Taylor & Francis

    Professor Howard Lee

  13. Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers

    Article • Drug Design Development and Therapy, January 2014, Taylor & Francis

    Professor Howard Lee